BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10526266)

  • 1. Concurrent chemoradiotherapy for esophageal carcinoma patients with malignant fistulae.
    Muto M; Ohtsu A; Miyamoto S; Muro K; Boku N; Ishikura S; Satake M; Ogino T; Tajiri H; Yoshida S
    Cancer; 1999 Oct; 86(8):1406-13. PubMed ID: 10526266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent chemoradiotherapy for esophageal cancer with malignant fistula.
    Koike R; Nishimura Y; Nakamatsu K; Kanamori S; Shibata T
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1418-22. PubMed ID: 18234437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of malignant esophagorespiratory fistula.
    Burt M
    Chest Surg Clin N Am; 1996 Nov; 6(4):765-76. PubMed ID: 8934007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemoradiotherapy followed by surgery in treatment of locally advanced esophageal carcinoma: a phase II trial].
    Fu JH; Rong TH; Li XD; Hu Y; Ou W; Hu YH; Li Q
    Ai Zheng; 2004 Nov; 23(11 Suppl):1473-6. PubMed ID: 15566661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantation of self-expanding metallic stent for patients with malignant stricture after failure of definitive chemoradiotherapy for T3 or T4 esophageal squamous cell carcinomas.
    Kaneko K; Ito H; Konishi K; Kurahashi T; Katagiri A; Katayose K; Kitahara T; Ohtsu A; Mitamura K
    Hepatogastroenterology; 2002; 49(45):699-705. PubMed ID: 12063973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus: a case-control study.
    Wong SK; Chiu PW; Leung SF; Cheung KY; Chan AC; Au-Yeung AC; Griffith JF; Chung SS; Ng EK
    Ann Surg Oncol; 2008 Feb; 15(2):576-82. PubMed ID: 18057993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expression of Bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapy.
    Kang SY; Han JH; Lee KJ; Choi JH; Park JI; Kim HI; Lee HW; Jang JH; Park JS; Kim HC; Kang S; Oh YT; Chun M; Kim JH; Sheen SS; Lim HY
    Clin Cancer Res; 2007 Jul; 13(14):4146-53. PubMed ID: 17634542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of planned esophagectomy after neoadjuvant chemoradiotherapy for advanced esophageal carcinomas.
    Kato H; Fukuchi M; Manda R; Faried A; Takita J; Nakajima M; Miyazaki T; Sohda M; Fukai Y; Masuda N; Tsukada K; Kuwano H
    Anticancer Res; 2004; 24(6):4091-6. PubMed ID: 15736457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multivariate prognostic analysis for patients with unresectable esophageal carcinoma after concurrent chemoradiotherapy].
    Chen EC; Liu MZ; Hu YH; Li QQ; Liu H; Cai L; Liu H; Lin HX; Huang Y; Wang HY; Cui NJ
    Ai Zheng; 2005 Jun; 24(6):731-4. PubMed ID: 15946490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
    Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
    Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
    Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma.
    Furuse J; Kinoshita T; Kawashima M; Ishii H; Nagase M; Konishi M; Nakagohri T; Inoue K; Ogino T; Ikeda H; Maru Y; Yoshino M
    Cancer; 2003 Mar; 97(5):1346-52. PubMed ID: 12599244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumonectomy after high-dose radiation and concurrent chemotherapy for nonsmall cell lung cancer.
    Daly BD; Fernando HC; Ketchedjian A; Dipetrillo TA; Kachnic LA; Morelli DM; Shemin RJ
    Ann Thorac Surg; 2006 Jul; 82(1):227-31. PubMed ID: 16798219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete 5-year follow-up of a prospective phase II trial of preoperative chemoradiotherapy for esophageal cancer.
    Posner MC; Gooding WE; Lew JI; Rosenstein MM; Lembersky BC
    Surgery; 2001 Oct; 130(4):620-6; discussion 626-8. PubMed ID: 11602892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
    Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
    Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 is a possible predictor of sensitivity to chemoradiotherapy for esophageal squamous cell carcinoma.
    Samejima R; Kitajima Y; Yunotani S; Miyazaki K
    Anticancer Res; 1999; 19(6C):5515-21. PubMed ID: 10697609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Concurrent chemotherapy and radiation therapy for unresectable locally advanced carcinoma of the esophagus. Phase II study and clinical review on literature].
    Fritz P; Stoll P; Wannenmacher M; Zierhut D
    Strahlenther Onkol; 2003 May; 179(5):328-36. PubMed ID: 12740660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.